IRCT20100601004076N27尚未招募3 期
Evaluating the Safety and Effectiveness of Septimeb in Patients with COVID-19 Referred to Selected Hospitals of Tehran University of Medical Sciences: A Clinical Trial Study (Phase III)
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Informed and voluntary oral and written consent of the patient or his / her guardian to participate in the study
- •Age over 18 years
- •SARS-CoV-2 virus PCR test positive or having one of the following conditions: Strong symptoms of COVID-19 disease, including fever, dry cough, and shortness of breath
- •CT scan (HRCT or Spiral CT) that shows involvement with Cornavirus (at least 40% of lung involvement), especially ground glass in the peripheral or base of the lungs
- •Patients suffering from life-threatening complications due to COVID-19 disease including ARDS, myocarditis, sepsis, cytokine storm (with ESR above 100 or platelet decline over 3 days or elevated D-Dimer above normal or LDH above normal).
排除标准
- •Individuals whose Covid-19 test has not been approved
- •Individuals who use drugs
- •Individuals who drink alcohol
- •Individuals who use immunosuppressive drugs
- •Individuals under chemotherapy or radiotherapy
- •Individuals who use growth hormone, testosterone and anabolic steroids
- •The patient is pregnant or breastfeeding.
研究者
相似试验
尚未招募
4 期
euroEPO in mild-moderate Alzheimer's disease amnesic variantNervous System DiseasesAlzheimer DiseaseCentral Nervous System DiseasesNeurodegenerative DiseasesBrain DiseasesTauopathiesNeurocognitive Disordersmild-moderate Alzheimer's diseaseMental DisordersDementiaRPCEC00000410Center of Molecular Immunology (CIM)1,456
已完成
不适用
A STUDY TO DETERMINE THE SAFETY AND EFFICACY OF STI571 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA THAT ARE HEMATOLOGICALLY OR CYGOGENICALLY RESISTANT OR REFRACTORY OR INTOLERANT TO THE ALPHA INTERFERO-C921 Chronic myeloid leukaemia [CML], BCR/ABL-positiveChronic myeloid leukaemia [CML], BCR/ABL-positiveC921PER-004-01OVARTIS BIOSCIENSES PERU S.A.,
已完成
不适用
Evaluation of the safety and effectiveness of the MID-C/ApiFix system in adolescent idiopathic scoliosis.1002837710005944Spinal curvatureNL-OMON43676Vrije Universiteit Medisch Centrum33
进行中（未招募）
Unknown
Safety and effectiveness clinical evaluation of the range of injectable medical devices HYDRAGEL C in facial aesthetic treatmentSubjects across groups present with moderate to severe facial aesthetic concerns, including peri-oral lines, nasolabial folds, lip volume deficits, and cheeks/cheekbones volume deficit, as gauged by various dermatological scalesSkin and Connective Tissue DiseasesISRCTN13586698ouna Aesthetics75
进行中（未招募）
不适用
Clinical study to evaluate the safety and effectiveness of the use of two hyaluronic acid injectable products (Perfectha® Derm Lidocaine and Perfectha® Deep Lidocaine) in the treatment of lipsFor Perfectha® Derm Lidocaine: very thin to thin lip volume and with lip contour somewhat well-defined to poorly definedfor Perfectha® Deep Lidocaine: thin to moderate lip volumeISRCTN72858148Sinclair Pharma68